Announcement
GENERAL: RUA: Cann Group granted TGA GMP for Mildura facility
11:20am
RUA
01/07/2022 11:20
GENERAL
NOT PRICE SENSITIVE
REL: 1120 HRS Rua Bioscience Limited
GENERAL: RUA: Cann Group granted TGA GMP for Mildura facility
Yesterday, Rua Bioscience's (NZX: RUA) partner, Cann Group (ASX: CAN), was
granted a GMP licence to manufacture therapeutic goods which includes GMP
testing at its Mildura facility.
In combination with the licences and permits issued by the Office of Drug
Control (ODC) of Australia earlier this year, the Mildura GMP Licence enables
Cann to manufacture Active Pharmaceutical Ingredients (API) and hard capsules
and to conduct GMP-approved activities at the facility's existing chemistry
and microbiology laboratories.
Cann is Rua's Australian strategic manufacturing, supply and technical
services partner as a result of Rua's purchase of Zalm Therapeutics.
Cann's new AUD $120m cultivation and processing facility at Mildura is
considered one of the largest and most advanced in Australasia. The first
stage of its construction is now operational and capable of producing 12,500
kilograms of dried cannabis flower per year. When complete, capacity at the
13.5-hectare facility will grow up to 70,000 kilograms. In a capital-light
strategy, Gisborne-based Rua is leveraging this scale to deliver a range of
medicinal cannabis products to multiple export markets.
Ends.
For more information, please contact:
Kerry Donovan
Communications Manager Rua Bioscience
Email: kerry.donovan@ruabio.com
Phone: 021 128 7689
End CA:00394729 For:RUA Type:GENERAL Time:2022-07-01 11:20:48
Click here
to view related attachments.
